wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33920800-C7AFA449-2845-4035-833A-8C1764AFDFD5
Q33920800-C7AFA449-2845-4035-833A-8C1764AFDFD5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33920800-C7AFA449-2845-4035-833A-8C1764AFDFD5
Investigational agents in development for the treatment of ovarian cancer
P2860
Q33920800-C7AFA449-2845-4035-833A-8C1764AFDFD5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33920800-C7AFA449-2845-4035-833A-8C1764AFDFD5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5133f37993343dc9d0477e35938e7a784b1cf036
P2860
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.